首页> 外文期刊>Journal of Avian Medicine and Surgery >Plasma concentrations of fluconazole after a single oral dose and administration in drinking water in cockatiels (Nymphicus hollandicus).
【24h】

Plasma concentrations of fluconazole after a single oral dose and administration in drinking water in cockatiels (Nymphicus hollandicus).

机译:单次口服剂量和在鹦鹉中的饮用水中施用氟康唑后的血浆浓度( Nymphicus hollandicus )。

获取原文
获取原文并翻译 | 示例
       

摘要

Candidiasis frequently affects the oropharynx, esophagus, and crop of juvenile birds with immature immune systems and adult birds that have received long-term antibiotic treatment. Fluconazole is used extensively in human medicine to treat mucosal and invasive candidiasis and has been used in birds; however, there have been few pharmacokinetic studies in avian species to guide safe and effective treatment. The purpose of the present study was to investigate the disposition of fluconazole in cockatiels (Nymphicus hollandicus) after single oral dose administration and to determine if therapeutic plasma concentrations could be safely achieved by providing medicated water. Twenty-eight cockatiels were placed into 7 groups and were orally administered a 10 mg/kg fluconazole suspension. Blood samples were collected from each group for plasma fluconazole assay at serial time points. Fluconazole-medicated drinking water was prepared daily and offered to 15 cockatiels at a concentration of 100 mg/L for 8 days. Blood was collected for plasma fluconazole assay at 2 time points on days 3 and 7. When using naive averaged data in the single-dose study, pharmacokinetic parameters were similar for both compartmental and noncompartmental analyses. The elimination half-life of fluconazole was 19.01 hours, maximum plasma concentration was 4.94 mg/mL, time until maximal concentration was 3.42 hours, and the area under the plasma concentration versus time curve (AUC) was 149.28 h x micro g/mL. Computer-simulated trough and peak plasma concentrations at steady-state after multiple doses of fluconazole at 10 mg/kg every 24 hours, 10 mg/kg every 48 hours, and 5 mg/kg every 24 hours were approximately 4.1-8.5 micro g/mL, 1.2-6.0 micro g/mL, and 2.0-4.3 micro g/mL, respectively. Mean+or-SD plasma fluconazole concentrations for the 100 mg/L medicated water study at 0800 and 1600 hours on day 3 were 3.69+or-1.22 mg/mL (range, 1.73-5.26 micro g/mL) and 4.17+or-1.96 micro g/mL (range, 3.58-7.49 micro g/mL), respectively, and at 0800 and 1600 hours on day 7 were 4.78+or-0.91 micro g/mL (range, 2.62-6.11 micro g/mL) and 6.61+or-1.67 micro g/mL (range, 3.76-8.78 micro g/mL), respectively. Treatment with fluconazole administered orally at a dosage of 5 mg/kg once daily or 10 mg/kg every 48 hours or fluconazole administered in the drinking water at a concentration of 100 mg/L is predicted to maintain plasma concentrations in most cockatiels that exceed the minimum inhibitory concentration of 90% or therapeutic AUC:MIC of most strains of Candida albicans (by using susceptibility data from humans). The compounded oral suspension was stable for 14 days when stored at 5 degrees C (41 degrees F) and protected from light.
机译:念珠菌病经常影响免疫系统不成熟的幼鸟和接受长期抗生素治疗的成年鸟的口咽,食道和作物。氟康唑在人类医学中广泛用于治疗粘膜和侵袭性念珠菌病,并已在鸟类中使用。但是,很少有关于禽类的药代动力学研究来指导安全有效的治疗。本研究的目的是研究单次口服给药后氟康唑在小形鹦鹉( Nymphicus hollandicus )中的处置,并确定通过提供药水能否安全地达到治疗性血浆浓度。将28只小鹦鹉分成7组,并口服给予10mg / kg的氟康唑悬浮液。从各组收集血样,在连续的时间点进行血浆氟康唑测定。每天准备氟康唑加药的饮用水,并以100 mg / L的浓度将其喂给15只小鹦鹉,持续8天。在第3天和第7天的2个时间点采集血液用于血浆氟康唑测定。在单剂量研究中使用纯朴的平均数据时,房室和非房室分析的药代动力学参数相似。氟康唑的消除半衰期为19.01小时,最大血浆浓度为4.94 mg / mL,到最大浓度的时间为3.42小时,血浆浓度-时间曲线下面积(AUC)为149.28 h x micro g / mL。氟康唑每24小时10 mg / kg,每48小时10 mg / kg和每24小时5 mg / kg多次给药后,计算机模拟的稳态谷浓度和峰值血浆浓度约为4.1-8.5 micro g / mL,1.2-6.0微克/毫升和2.0-4.3微克/毫升。在第3天的0800和1600小时,100 mg / L药用水研究的氟康唑血浆平均或SD浓度为3.69 +或1.22 mg / mL(范围1.73-5.26 micro g / mL)和4.17 +或-分别为1.96 micro g / mL(范围3.58-7.49 micro g / mL)和第7天0800和1600小时的4.78+或-0.91 micro g / mL(范围2.62-6.11 micro g / mL)和分别为6.61 +或1.67 micro g / mL(范围3.76-8.78 micro g / mL)。预计口服氟康唑的剂量为每天一次5 mg / kg或每48小时10 mg / kg的剂量,或以100 mg / L的浓度在饮用水中给予氟康唑的治疗可使大多数鹦鹉的血浆浓度保持在多数白色念珠菌菌株的最小抑菌浓度为90%或治疗性AUC:MIC(使用来自人类的药敏数据)。当在5摄氏度(41华氏度)下储存时,复合口服混悬液可稳定保存14天,并避光。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号